SEC Form 4 · accession 0001209191-15-070880
KYNTRA BIO, INC. · KYNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Pat Cotroneo
Officer — VP, Finance and CFO
Period of report
Sep 11, 2015
Accepted (ET)
Sep 15, 2015 · 8:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921299
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 11, 2015 | M | 1,340 | $2.90 | A | 108,591 | D | |
| Common Stock | Sep 15, 2015 | S | 1,093 | $27.95 | D | 107,498 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $2.90 | Sep 8, 2015 | M | 1,340 | D | — | Jun 24, 2020 | Common Stock | 1,340 | 2,400 | D |
Explanation of responses
- F1Shares sold pursuant to a 10b5-1 plan.
- F2Fully vested.